P.A.W. Capital Corp Galapagos Nv Transaction History

P.A.W. Capital Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 26, 2018	SELL	$94.51 - $120.23 $283,530 - $360,690	-3,000 Reduced 25.0%	9,000 $898,000
Q4 2017 Jan 31, 2018	BUY	$84.48 - $104.02 $168,960 - $208,040	2,000 Added 20.0%	12,000 $1.13 Million
Q3 2017 Oct 23, 2017	BUY	$73.17 - $103.47 $731,700 - $1.03 Million	10,000	10,000 $1.02 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.